Iron Triangle Partners LP
- SEC CIK
- 0001779763
- 最新申報
- 2026/2/17
2023 年第 4 季持倉
持倉截至 2023/12/31，2024/2/14 申報。只含多頭部位，變化是跟 2023 年第 3 季比股數。
- 持股檔數
- 26
- 較 2023 年第 3 季 +3
- 總值
- $7.73 億
- 較 2023 年第 3 季 +$8,867 萬 (+13.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ACHCAcadia Healthcare Company, Inc. | COM | 791,993 | $6,159 萬 | 8.0% | +26,789+3.5% | 加碼 | 歷史 |
| UHSUniversal Health Services Inc | CL B | 321,886 | $4,907 萬 | 6.3% | −179,914−35.9% | 減碼 | 歷史 |
| ICLRIcon PLC | COM | 172,675 | $4,888 萬 | 6.3% | +42,675+32.8% | 加碼 | 歷史 |
| ELANElanco Animal Health Inc | COM | 3,000,000 | $4,470 萬 | 5.8% | −412,350−12.1% | 減碼 | 歷史 |
| IDXXIDEXX Laboratories Inc | COM | 76,025 | $4,220 萬 | 5.5% | +76,025 | 新進 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 120,000 | $4,048 萬 | 5.2% | −22,000−15.5% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 250,000 | $3,874 萬 | 5.0% | 00.0% | 不變 | 歷史 |
| MCKMcKesson Corp | Stock | 80,000 | $3,704 萬 | 4.8% | +10,000+14.3% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 290,000 | $3,599 萬 | 4.7% | −275,753−48.7% | 減碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 1,044,530 | $3,341 萬 | 4.3% | +1,044,530 | 新進 | 歷史 |
| BRKRBruker Corp | COM | 450,000 | $3,307 萬 | 4.3% | +19,157+4.4% | 加碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 220,000 | $3,063 萬 | 4.0% | +220,000 | 新進 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 150,000 | $3,051 萬 | 3.9% | +150,000 | 新進 | 歷史 |
| BKDBrookdale Senior Living Inc. | COM | 4,859,607 | $2,828 萬 | 3.7% | +623,479+14.7% | 加碼 | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 479,374 | $2,683 萬 | 3.5% | −187,571−28.1% | 減碼 | 歷史 |
| SNYSanofi | SPONSORED ADR | 500,000 | $2,487 萬 | 3.2% | +500,000 | 新進 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 380,000 | $2,286 萬 | 3.0% | −72,629−16.0% | 減碼 | 歷史 |
| GKOSGLAUKOS Corp | COM | 244,606 | $1,944 萬 | 2.5% | −185,394−43.1% | 減碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 200,000 | $1,928 萬 | 2.5% | +200,000 | 新進 | 歷史 |
| OSCROscar Health, Inc. | CL A | 2,052,551 | $1,878 萬 | 2.4% | +2,052,551 | 新進 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 1,843,278 | $1,808 萬 | 2.3% | +43,278+2.4% | 加碼 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 468,585 | $1,678 萬 | 2.2% | +468,585 | 新進 | 歷史 |
| RGENRepligen Corp | COM | 82,537 | $1,484 萬 | 1.9% | +82,537 | 新進 | 歷史 |
| MASS908 Devices Inc. | COM | 1,284,947 | $1,442 萬 | 1.9% | +304,484+31.1% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,300,000 | $1,357 萬 | 1.8% | +1,300,000 | 新進 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 331,238 | $857.6 萬 | 1.1% | −238,888−41.9% | 減碼 | 歷史 |
2023 年第 3 季之後清倉（7 檔）
2023 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 3 季股數 | 2023 年第 3 季市值 | 2023 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 210,635 | $4,758 萬 | 7.0% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 880,000 | $3,348 萬 | 4.9% | 歷史 |
| BSXBoston Scientific Corp | Stock | 400,000 | $2,112 萬 | 3.1% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 330,549 | $1,722 萬 | 2.5% | 歷史 |
| EXASExact Sciences Corp | COM | 250,000 | $1,706 萬 | 2.5% | 歷史 |
| Olink Hldg AB680710100 | SPONSORED ADS | 738,062 | $1,089 萬 | 1.6% | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 150,211 | $347.3 萬 | 0.5% | 歷史 |